Karasawa A, Kubo K, Shuto K, Oka T, Nakamizo N
Pharmaceutical Research Laboratories, Kyowa Hakko Kogyo Co., Ltd., Shizuoka, Japan.
Arzneimittelforschung. 1988 Nov;38(11A):1702-7.
Antianginal effects of (+/-)-(R*)-2,6-dimethyl-4-(m-nitrophenyl)- 1,4-dihydropyridine-3,5-dicarboxylic acid (R*)-1-benzyl-3-piperidinyl ester, methyl ester hydrochloride (benidipine hydrochloride, KW-3049) in various experimental angina-pectoris models (anesthetized rats, spontaneously hypertensive rats (SHR] were compared with those of nifedipine, propranolol and hydralazine. Furthermore, the effects of these drugs on the pressure-rate product were evaluated. 1. Vasopressin test (SHR): The administration of KW-3049 at 10 micrograms/kg (i.v.) developed an inhibitory effect comparable to that of nifedipine at 200 micrograms/kg (i.v.) against the ischemic ECG changes caused by the intravenous administration of vasopressin at 1 U/kg. The effects of KW-3049 at 3 and 10 mg/kg (p.o.) lasted for 8 h or more. 2. Coronary occlusion test (rat): The rise of T-wave of epicardial ECG following ligation of coronary artery was inhibited by the administration of KW-3049 at doses of 30 and 100 micrograms/kg i.v. Nifedipine at dose of 200 micrograms/kg i.v. was slightly effective. 3. Isoproterenol (isoprenaline) test (rat): The fall of ST in ECG by the continuous infusion of isoprenaline (10 micrograms/kg/min) was almost completely prevented by propranolol (500 micrograms/kg i.v.). Also, KW-3049 (200 micrograms/kg i.v.) and nifedipine (200 micrograms/kg i.v.) significantly inhibited the decline of ST, in which the former was more effective than the latter. 4. Anoxia test (SHR): The fall of ST and rise of T-wave of ECG, induced by stopping artificial respiration of gallamine-immobilized SHR, were suppressed by the administration of KW-3049 at doses of 10 and 30 micrograms/kg i.v.(ABSTRACT TRUNCATED AT 250 WORDS)
将(±)-(R*)-2,6-二甲基-4-(间硝基苯基)-1,4-二氢吡啶-3,5-二羧酸(R*)-1-苄基-3-哌啶酯盐酸甲酯(盐酸贝尼地平,KW-3049)在各种实验性心绞痛模型(麻醉大鼠、自发性高血压大鼠(SHR))中的抗心绞痛作用与硝苯地平、普萘洛尔和肼屈嗪的作用进行了比较。此外,还评估了这些药物对压力-心率乘积的影响。1. 血管加压素试验(SHR):静脉注射10微克/千克的KW-3049产生的抑制作用与静脉注射200微克/千克的硝苯地平对静脉注射1单位/千克血管加压素引起的缺血性心电图变化的抑制作用相当。口服3毫克/千克和10毫克/千克的KW-3049的作用持续8小时或更长时间。2. 冠状动脉结扎试验(大鼠):静脉注射30微克/千克和100微克/千克的KW-3049可抑制冠状动脉结扎后心外膜心电图T波的升高。静脉注射200微克/千克的硝苯地平效果稍差。3. 异丙肾上腺素试验(大鼠):持续输注异丙肾上腺素(10微克/千克/分钟)导致的心电图ST段下降几乎被静脉注射500微克/千克的普萘洛尔完全预防。此外,静脉注射200微克/千克的KW-3049和硝苯地平也显著抑制ST段下降,前者比后者更有效。4. 缺氧试验(SHR):静脉注射10微克/千克和30微克/千克的KW-3049可抑制加拉明固定的SHR停止人工呼吸后引起的心电图ST段下降和T波升高。(摘要截断于250字)